Löscher W
Naunyn Schmiedebergs Arch Pharmacol. 1981 Sep;317(2):131-4. doi: 10.1007/BF00500068.
The intraperitoneal administration of gabaculine, aminooxyacetic acid (s.c.), gamma-acetylenic GABA, gamma-vinyl GABA, ethanolamine-O-sulphate, sodium valproate and GABA caused significant increases in the GABA content of both the whole brain and brain nerve endings (synaptosomes) in mice, a linear relationship being observed between the two parameters. When the relative effects on GABA concentrations were compared with the potency of the different drugs to elevate the thresholds for electroconvulsions and clonic pentetrazole seizures, only the increase in the pentetrazole seizure threshold was significantly correlated with the elevation of brain and synaptosomal GABA content. The present results indicate that the threshold for pentetrazole seizures is an appropriate test-system to study the relationship between alterations of overall GABA levels in the brain and nerve terminals and anticonvulsant activity of GABA-elevating agents.
腹腔注射加巴喷丁、氨基氧乙酸(皮下注射)、γ-乙炔基 GABA、γ-乙烯基 GABA、乙醇胺-O-硫酸盐、丙戊酸钠和 GABA 可使小鼠全脑和脑神经末梢(突触体)中的 GABA 含量显著增加,两个参数之间呈线性关系。当将不同药物对 GABA 浓度的相对影响与提高电惊厥和阵挛性戊四氮惊厥阈值的效力进行比较时,只有戊四氮惊厥阈值的升高与脑和突触体 GABA 含量的升高显著相关。目前的结果表明,戊四氮惊厥阈值是研究脑和神经末梢中总体 GABA 水平变化与 GABA 升高剂抗惊厥活性之间关系的合适测试系统。